From Yahoo Finance: 2025-04-26 12:01:00

Truist analyst Richard Newitter raised Integer’s price target to $150 from $140, maintaining a Buy rating. Q1 results beat estimates with strength in Cardio and Vascular. Fiscal 2025 guidance of 8%-10% organic growth was reiterated, with increased EPS guidance. Truist sees upside potential and believes the company can grow profitably above its end markets.



Read more at Yahoo Finance: Integer price target raised to $150 from $140 at Truist